Coinfection by Mucoraceae and Aspergillus Species in a Patient With Acute Leukemia: A Clinical Case Report

Atousa Hakamifard1,2, Mohammadsaleh Peikar3, Seyed Amirhossein Dormiani Tabatabaei4

  • 1Department of Infectious Diseases, School of Medicine Isfahan University of Medical Sciences Isfahan Iran.

Clinical Case Reports
|February 12, 2025
PubMed

Insights

Concurrent invasive fungal infections by Aspergillus and Mucoraceae species are rare in hematologic patients. Prompt diagnosis and treatment are crucial for improving outcomes in these immunocompromised individuals.

Area of Science:

  • Mycology
  • Hematology
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to immunocompromised patients, particularly those with hematologic malignancies.
  • Concurrent infections by multiple fungal species are exceptionally rare but associated with high mortality.
  • Early diagnosis and treatment are critical for patient survival.

Purpose of the Study:

  • To report a rare case of concomitant invasive fungal infections caused by distinct fungal species in a hematologic patient.
  • To emphasize the diagnostic and therapeutic challenges posed by such co-infections.
  • To highlight the need for optimized management strategies in immunocompromised hosts.

Main Methods:

  • Case report of a patient with pre-B-cell acute lymphoblastic leukemia.
  • Diagnosis involved identification of concurrent acute invasive fungal rhinosinusitis (AIFR) and invasive pulmonary fungal infection.
  • Fungal etiologies identified as Aspergillus and Mucoraceae species.

Main Results:

  • Successful identification of a dual fungal infection involving Aspergillus and Mucoraceae species.
  • The patient presented with both rhinosinusitis and pulmonary involvement.
  • This case underscores the complexity of managing IFIs in severely immunocompromised individuals.

Conclusions:

  • Concurrent invasive fungal infections by different fungal species are a critical clinical challenge.
  • This case highlights the importance of considering multiple pathogens in immunocompromised patients with IFIs.
  • Further research is needed to develop effective treatment protocols for these complex infections.